skip to main content
Idioma:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Busca Simples
Resultados 1 2 3 4 5 next page
Refinado por: Base de dados/Biblioteca: EBSCOhost Academic Search Premier remover assunto: Male remover assunto: Medical Sciences remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysis
Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysis

KHOURY, H. J ; KUKREJA, M ; GALE, R. P ; MARKS, D. I ; MCCARTHY, P. L ; WOOLFREY, A ; SZER, J ; GIRALT, S. A ; MAZIARZ, R. T ; CORTES, J ; HOROWITZ, M. M ; LEE, S. J ; GOLDMAN, J. M ; WANG, T ; HALTER, J ; ARORA, M ; GUPTA, V ; RIZZIERI, D. A ; GEORGE, B ; KEATING, A

Bone marrow transplantation (Basingstoke), 2012-06, Vol.47 (6), p.810-816 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
2
Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatment
Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatment
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatment

KANDA, J ; KAYNAR, L ; GASPARETTO, C ; CHUTE, J. P ; MORRIS, A ; WINKEL, S ; MCPHERSON, J ; KURTZBERG, J ; CHAO, N. J ; HORWITZ, M. E ; KANDA, Y ; PRASAD, V. K ; PARIKH, S. H ; LAN, L ; SHEN, T ; RIZZIERI, D. A ; LONG, G. D ; SULLIVAN, K. M

Bone marrow transplantation (Basingstoke), 2013-07, Vol.48 (7), p.926-931 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
3
Preemptive dosing of plerixafor given to poor stem cell mobilizers on day 5 of G-CSF administration
Preemptive dosing of plerixafor given to poor stem cell mobilizers on day 5 of G-CSF administration
Material Type:
Artigo 		Adicionar ao Meu Espaço

Preemptive dosing of plerixafor given to poor stem cell mobilizers on day 5 of G-CSF administration

HORWITZ, M. E ; CHUTE, J. P ; GASPARETTO, C ; LONG, G. D ; MCDONALD, C ; MORRIS, A ; RIZZIERI, D. A ; SULLIVAN, K. M ; CHAO, N. J

Bone marrow transplantation (Basingstoke), 2012-08, Vol.47 (8), p.1051-1055 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
4
Outcomes of a 1-day nonmyeloablative salvage regimen for patients with primary graft failure after allogeneic hematopoietic cell transplantation
Outcomes of a 1-day nonmyeloablative salvage regimen for patients with primary graft failure after allogeneic hematopoietic cell transplantation
Material Type:
Artigo 		Adicionar ao Meu Espaço

Outcomes of a 1-day nonmyeloablative salvage regimen for patients with primary graft failure after allogeneic hematopoietic cell transplantation

KANDA, J ; HORWITZ, M. E ; RIZZIERI, D. A ; LONG, G. D ; GASPARETTO, C ; SULLIVAN, K. M ; CHUTE, J. P ; MORRIS, A ; HENNIG, T ; LI, Z ; CHAO, N. J

Bone marrow transplantation (Basingstoke), 2012-05, Vol.47 (5), p.700-705 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
5
Differential impact of inhibitory and activating Killer Ig-Like Receptors (KIR) on high-risk patients with myeloid and lymphoid malignancies undergoing reduced intensity transplantation from haploidentical related donors
Differential impact of inhibitory and activating Killer Ig-Like Receptors (KIR) on high-risk patients with myeloid and lymphoid malignancies undergoing reduced intensity transplantation from haploidentical related donors
Material Type:
Artigo 		Adicionar ao Meu Espaço

Differential impact of inhibitory and activating Killer Ig-Like Receptors (KIR) on high-risk patients with myeloid and lymphoid malignancies undergoing reduced intensity transplantation from haploidentical related donors

CHEN, D.-F ; PRASAD, V. K ; LONG, G. D ; YANG, Y ; CHAO, N. J ; RIZZIERI, D. A ; BROADWATER, G ; REINSMOEN, N. L ; DEOLIVEIRA, A ; CLARK, A ; SULLIVAN, K. M ; CHUTE, J. P ; HORWITZ, M. E ; GASPARETTO, C

Bone marrow transplantation (Basingstoke), 2012-06, Vol.47 (6), p.817-823 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
6
Apolipoprotein E genotype as a determinant of survival in chronic lymphocytic leukemia
Apolipoprotein E genotype as a determinant of survival in chronic lymphocytic leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Apolipoprotein E genotype as a determinant of survival in chronic lymphocytic leukemia

WEINBERG, J. B ; VOLKHEIMER, A. D ; RIZZIERI, D. A ; LEVESQUE, M. C ; DEKROON, R ; STRITTMATTER, W. J ; MIHOVILOVIC, M ; JIANG, N ; CHEN, Y ; BOND, K ; MOORE, J. O ; GOCKERMAN, J. P ; DIEHL, L. F ; DE CASTRO, C. M

Leukemia, 2008-12, Vol.22 (12), p.2184-2192 [Periódico revisado por pares]

Avenel, NJ: Nature Publishing Group

Texto completo disponível

Citações Citado por
7
Early post transplant (F-18) 2-fluoro-2-deoxyglucose positron emission tomography does not predict outcome for patients undergoing auto-SCT in non-Hodgkin and Hodgkin lymphoma
Early post transplant (F-18) 2-fluoro-2-deoxyglucose positron emission tomography does not predict outcome for patients undergoing auto-SCT in non-Hodgkin and Hodgkin lymphoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Early post transplant (F-18) 2-fluoro-2-deoxyglucose positron emission tomography does not predict outcome for patients undergoing auto-SCT in non-Hodgkin and Hodgkin lymphoma

PALMER, J ; GOGGINS, T ; BROADWATER, G ; CHAO, N ; HORWITZ, M ; BEAVEN, A ; SULLIVAN, K ; COLEMAN, R. E ; RIZZIERI, D

Bone marrow transplantation (Basingstoke), 2011-06, Vol.46 (6), p.847-851 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
8
Clearance of HHV-8 from peripheral blood mononuclear cells with a protease inhibitor
Clearance of HHV-8 from peripheral blood mononuclear cells with a protease inhibitor
Material Type:
Artigo 		Adicionar ao Meu Espaço

Clearance of HHV-8 from peripheral blood mononuclear cells with a protease inhibitor

Rizzieri, David A ; Liu, Jane ; Traweek, S Thomas ; Miralles, G Diego

The Lancet (British edition), 1997-03, Vol.349 (9054), p.775-776 [Periódico revisado por pares]

London: Elsevier Ltd

Texto completo disponível

Citações Citado por
9
A Phase I Study of Arsenic Trioxide (Trisenox), Ascorbic Acid, and Bortezomib (Velcade) Combination Therapy in Patients With Relapsed/Refractory Multiple Myeloma
A Phase I Study of Arsenic Trioxide (Trisenox), Ascorbic Acid, and Bortezomib (Velcade) Combination Therapy in Patients With Relapsed/Refractory Multiple Myeloma
Material Type:
Artigo 		Adicionar ao Meu Espaço

A Phase I Study of Arsenic Trioxide (Trisenox), Ascorbic Acid, and Bortezomib (Velcade) Combination Therapy in Patients With Relapsed/Refractory Multiple Myeloma

Held, Lauren A. ; Rizzieri, David ; Long, Gwynn D. ; Gockerman, Jon P. ; Diehl, Louis F. ; Castro, Carlos M. de ; Moore, Joseph O. ; Horwitz, Mitchell E. ; Chao, Nelson J. ; Gasparetto, Cristina

Cancer investigation, 2013-03, Vol.31 (3), p.172-176 [Periódico revisado por pares]

New York, NY: Informa Healthcare

Texto completo disponível

Citações Citado por
10
Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS
Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS
Material Type:
Artigo 		Adicionar ao Meu Espaço

Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS

LUGER, S. M ; RINGDEN, O ; GIRALT, S. A ; GULBAS, Z ; GUPTA, V ; HALE, G. A ; LAZARUS, H. M ; LEWIS, V. A ; LILL, M. C ; MCCARTHY, P. L ; WEISDORF, D. J ; PULSIPHER, M. A ; ZHANG, M.-J ; PEREZ, W. S ; BISHOP, M. R ; BORNHAUSER, M ; BREDESON, C. N ; CAIRO, M. S ; COPELAN, E. A ; GALE, R. P

Bone marrow transplantation (Basingstoke), 2012-02, Vol.47 (2), p.203-211 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar
  1. Antes de2002  (2)
  2. 2002Até2004  (3)
  3. 2005Até2006  (7)
  4. 2007Até2009  (13)
  5. Após 2009  (36)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.